Related references
Note: Only part of the references are listed.A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain
Jeffrey Gudin et al.
PAIN AND THERAPY (2020)
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
M. Fallon et al.
ANNALS OF ONCOLOGY (2018)
Efficacy and adverse effects of buprenorphine in acute pain management: systematic review and meta-analysis of randomised controlled trials
L. D. White et al.
BRITISH JOURNAL OF ANAESTHESIA (2018)
Supportive care in cancer: new directions to achieve universal access to psychosocial, palliative, and end-of-life care
Stein Kaasa et al.
Lancet Global Health (2018)
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids
O. Corli et al.
ANNALS OF ONCOLOGY (2016)
Opioid switch from low dose of oral oxycodone to transdermal fentanyl matrix patch for patients with stable thoracic malignancy-related pain
Seigo Minami et al.
BMC PALLIATIVE CARE (2014)
Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland
Anna Przeklasa-Muszynska et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Transdermal opioids for cancer pain
Elaine Cachia et al.
Current Opinion in Supportive and Palliative Care (2011)
Transdermal buprenorphine for the treatment of cancer pain: results from a multicenter, observational, post-marketing study in Spain (RELIEF study)
Carlos Camps et al.
PAIN MANAGEMENT (2011)
Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes
H. Breivik et al.
ANNALS OF ONCOLOGY (2009)
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
M. H. J. Van den Beuken-Van Everdingen et al.
ANNALS OF ONCOLOGY (2007)
Patterns of dosage changes with transidermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: A retrospective data analysis in Germany
Reinhard Sittl et al.
CLINICAL THERAPEUTICS (2006)
Transdermal buprenorphine in clinical practice - a post-marketing surveillance study in 13179 patients
N Griessinger et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: Results of a retrospective cohort study
R Sittl et al.
CLINICAL THERAPEUTICS (2005)
Transdermal buprenorphine in the treatment of chronic pain: Results of a Phase III, multicenter, randomized, double-blind, placebo-controlled study
J Sorge et al.
CLINICAL THERAPEUTICS (2004)
Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study
K Bohme et al.
PAIN CLINIC (2003)
Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: A multicenter, randomized, double-blind, placebo-controlled trial
R Sittl et al.
CLINICAL THERAPEUTICS (2003)
Share Paper
